The AGA says that no data has been found to support all patients stopping the medications prior to elective endoscopy procedures, but rather suggests that patients should consult their physicians for individualized guidance, according to a Nov. 7 press release sent to Becker’s.
The statement is in response to a statement from the American Society of Anesthesiologists calling for all patients to stop taking the medications prior to elective procedures and surgeries.
The AGA encourages physicians to consider three things when treating patients on GLP-1 RAs undergoing endoscopic procedures: First, proceed with the procedure as planned for patients on GLP-1 RAs who followed the standard pre-procedure fasting instructions. Second, in lieu of stopping GLP-1 RAs, patients can also be placed on a liquid diet one day prior to the procedure. Third, in patients with symptoms suggesting retained gastric contents, a potential side effect of the drugs, consider rapid-sequence intubation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.